Hospital

Study results show that annual screening can identify cases of prostate cancer up to 8 times as often in those with hereditary Lynch syndrome than in those who do not get the tests.

Jameshia Below, PharmD, an assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, explains what the most common complications from cancer treatment are that can lead to oncologic emergencies and how can they be identified.

New study results show that single-dose vaccination may benefit populations with limited supplies.

The first “National Pharmaceutical Week” was proposed at the 1924 APhA annual meeting. In 1925, the inaugural week celebrating pharmacy was held from October 11 to 17.

Clinical testing of COVID-19 vaccine efficacy has led to the first FDA-approved COVID-19 vaccine, Comirnaty.

New legislation is set to ensure the availability of home infusions for certain Medicare patients.

Sumaya Jaludi, PharmD, instructor for pharmacy technology at Carrington College, discusses the importance of pharmacy technicians for National Pharmacy Technician Day, especially during the COVID-19 pandemic.

Jennifer Andrews, MD, pediatric hematologist-oncologist at Vanderbilt University Medical Center and medical director of Vanderbilt University Medical Center’s blood bank, discusses what the national blood shortage may mean for health systems.

Survey results from COVID-19 Vaccine Education and Equity Project shows desire to protect kids from getting the coronavirus.

As inflammation worsens, appendicitis pain typically increases and eventually becomes severe.

Monitoring for AEs, educating about drug regimens, and managing therapies are opportunities for pharmacists to make a difference.

Officials with the FDA have approved Zimhi 5 mg/0.5 mL, a high-dose naloxone injection product, for use in the treatment of opioid overdose.

According to Genentech, atezolizumab is the first and only cancer immunotherapy approved for adjuvant treatment of NSCLC.

Northwestern Medicine study results show that mice were protected from other strains when those from prior infections or in their vaccinations were greater than 70%.

The COVID-19 pandemic and the rapid digital adoption of mobile devices have changed the role of the community pharmacist.

The efficacy of Latuda in schizophrenia and bipolar depression could be mediated through a combination of central dopamine D2 and serotonin type 2 receptor antagonism.

Causes of aortic valve stenosis include congenital heart defect, calcium build-up on the valve, and rheumatic fever.

The Next-Generation Pharmacist Awards national program salutes pharmacy professionals who are defining the industry’s future.

A booster shot of the Johnson & Johnson single-shot vaccine administered 56 days after the initial shot provided 94% protection against COVID-19.

Although the advisory committee’s recommendation is not binding, the FDA will take their recommendation into consideration when making a final decision on authorization of the 50-µg booster dose.

A panel overview of the important topics happening in pharmacy, such as the role of technicians growing in the field, COVID-19’s impact on their work, and what they feel the value of a pharmacist is. Happy American Pharmacists Month!

Causes of atrial flutter include hypertension, cardiomyopathy, abnormal heart valve, hypertrophy, hyperthyroidism, and pulmonary embolism.

Lindy Bancke, PharmD, head of clinical development at Rebiotix Inc, said the clinical development program of RBX2660 is showing promise in the treatment of recurrent C. Difficile infection.

The agency has a 2-day meeting scheduled for this week for an independent advisory panel to discuss the available data.

Approximately 25% to 35% of new oncology therapies in development are oral medications.

Pembrolizumab (Keytruda) approved by FDA in combination with chemotherapy, with or without bevacizumab (Avastin), in patients with persistent, recurrent, or metastatic cervical cancer.

Early intervention with ocrelizumab resulted in a 35% reduction of risk in individuals with RMS who needed a walking aid over 7 and a half years.

Maralixibat decreases the reabsorption of bile acids from the terminal ileum for the treatment of cholestatic pruritus in patients with Alagille syndrome.